Virax Biolabs Group (NASDAQ:VRAX) Versus Lucira Health (NASDAQ:LHDXQ) Head to Head Contrast
Virax Biolabs Group (NASDAQ:VRAX) Versus Lucira Health (NASDAQ:LHDXQ) Head to Head Contrast
Virax Biolabs Group (NASDAQ:VRAX – Get Rating) and Lucira Health (NASDAQ:LHDXQ – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.
Virax Biolabs Group（纳斯达克股票代码：VRAX — 获取评级）和 Lucira Health（纳斯达克股票代码：LHDXQ — 获取评级）都是小型医疗公司，但哪家企业更好？我们将根据两家企业的风险实力、估值、分析师建议、股息、机构所有权、盈利能力和收益对比这两家企业。
Profitability
盈利能力
This table compares Virax Biolabs Group and Lucira Health's net margins, return on equity and return on assets.
该表比较了Virax Biolabs集团和Lucira Health的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Virax Biolabs Group | N/A | N/A | N/A |
| Lucira Health | -67.54% | -13.55% | -8.47% |
| 净利润 | 股本回报率 | 资产回报率 | |
| Virax Biolabs 集团 | 不适用 | 不适用 | 不适用 |
| 露西拉健康 | -67.54% | -13.55% | -8.47% |
Valuation & Earnings
估值与收益
This table compares Virax Biolabs Group and Lucira Health's revenue, earnings per share (EPS) and valuation.
该表比较了Virax Biolabs Group和Lucira Health的收入、每股收益（EPS）和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Virax Biolabs Group | $120,000.00 | 62.21 | -$1.71 million | N/A | N/A |
| Lucira Health | $93.06 million | 0.05 | -$64.83 million | ($3.58) | -0.04 |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| Virax Biolabs 集团 | 120,000.00 美元 | 62.21 | -171 万美元 | 不适用 | 不适用 |
| 露西拉健康 | 9306 万美元 | 0.05 | -6,483 万美元 | (3.58 美元) | -0.04 |
Virax Biolabs Group has higher earnings, but lower revenue than Lucira Health.
Virax Biolabs Group的收益更高，但收入低于Lucira Health。
Analyst Ratings
分析师评级
This is a breakdown of current recommendations for Virax Biolabs Group and Lucira Health, as reported by MarketBeat.com.
据Marketbeat.com报道，这是目前对Virax Biolabs Group和Lucira Health的建议的明细。
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Virax Biolabs Group | 0 | 0 | 0 | 0 | N/A |
| Lucira Health | 0 | 0 | 0 | 0 | N/A |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| Virax Biolabs 集团 | 0 | 0 | 0 | 0 | 不适用 |
| 露西拉健康 | 0 | 0 | 0 | 0 | 不适用 |
Institutional and Insider Ownership
机构所有权和内部所有权
0.5% of Virax Biolabs Group shares are owned by institutional investors. Comparatively, 57.0% of Lucira Health shares are owned by institutional investors. 45.1% of Virax Biolabs Group shares are owned by company insiders. Comparatively, 30.4% of Lucira Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Virax Biolabs集团的0.5％股份由机构投资者持有。相比之下，Lucira Health的股票中有57.0％由机构投资者持有。Virax Biolabs集团45.1％的股票由公司内部人士拥有。相比之下，Lucira Health的股份中有30.4％由公司内部人士持有。强大的机构所有权表明捐赠基金、大型基金经理和对冲基金认为，从长远来看，股票的表现将优于市场。
Summary
摘要
Virax Biolabs Group beats Lucira Health on 6 of the 8 factors compared between the two stocks.
Virax Biolabs Group在两只股票比较的8个因素中有6个击败了Lucira Health。
About Virax Biolabs Group
关于 Virax Biolabs 集团
(Get Rating)
（获取评分）
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name, as well as infrared thermometers, pulse oximeters, masks, gloves, and other PPE products. It also distributes nebulizing machines and smart wearable devices that alert employees to help them follow social distance guidelines. In addition, the company operates an online platform that sells ViraxClear and ViraxCare products. It serves clinics, pharmacies, laboratories, hospitals, and other groups, as well as corporations, employees, individual consumers, hospital systems, and public and private institutions. The company operates in Europe, South America, the Asia Pacific, Sub-Saharan Africa, and internationally. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was incorporated in 2021 and is headquartered in London, the United Kingdom.
生物技术公司Virax Biolabs Group Limited销售、分销和销售诊断测试套件以及医疗技术和个人防护设备产品，用于免疫学领域病毒性疾病的预防、检测、诊断和风险管理。该公司以ViraxClear品牌提供快速抗体IgC/IgM测试、抗原测试、聚合酶链反应快速测试和中和抗体测试；以及医疗技术和个人防护设备产品，例如ViraxCare品牌的员工保护设备产品，以及红外温度计、脉搏血氧仪、口罩、手套和其他个人防护设备产品。它还分发雾化机和智能可穿戴设备，提醒员工帮助他们遵守社交距离准则。此外，该公司还运营着一个销售ViraxClear和ViraxCare产品的在线平台。它为诊所、药房、实验室、医院和其他团体以及公司、员工、个人消费者、医院系统以及公共和私人机构提供服务。该公司在欧洲、南美、亚太地区、撒哈拉以南非洲和国际上开展业务。该公司前身为Virax Biolabs（开曼）有限公司，并于2021年9月更名为Virax Biolabs Group Limited。Virax Biolabs Group Limited成立于2021年，总部位于英国伦敦。
About Lucira Health
关于 Lucira Health
(Get Rating)
（获取评分）
Lucira Health Inc. is a medical technology company. It is focused on the development and commercialization of transformative and infectious disease test kits. Lucira Health Inc. is based in Emeryville, California.
Lucira Health Inc. 是一家医疗技术公司。它专注于变革性和传染病检测试剂盒的开发和商业化。Lucira Health Inc. 总部位于加利福尼亚州的埃默里维尔。
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收 Virax Biolabs Group 的新闻和收视率 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Virax Biolabs Group及相关公司最新新闻和分析师评级的简明每日摘要。